Go back to all articles
NT-proBNP
These tests measure the concentration of B-type natriuretic peptide (BNP) or N-terminal pro b-type natriuretic peptide (NT-proBNP) in the blood in order to detect and evaluate heart failure. BNP was initially called brain natriuretic peptide because it was first found in brain tissue (and to distinguish it from a similar protein made in the atria, or upper chambers, of the heart, termed ANP). BNP is actually produced primarily by the left ventricle of the heart (the heart’s main pumping chamber). It is associated with blood volume and pressure and with the work that the heart must do in pumping blood throughout the body. Small amounts of a precursor protein, pro-BNP, are continuously produced by the heart. Pro-BNP is then cleaved to release the active hormone BNP and an inactive fragment, NT-proBNP, into the blood.
Sample
Blood (serum)
Reference
Less than 125 pg/ml
Frequency
Twice a week
This article could be of your interest
News
01/04/24
Tackling the Rising Demand for Diagnostic Testing
Planned efforts by stakeholders in the healthcare industry may resolve the challenges in diagnostic testing
READ MORE
News
01/04/24
Global Sustainability Survey Reports Progress Toward Greener Labs
Laboratories seek to actively participate and accelerate sustainability efforts
READ MORE
News
13/03/24
Why do we have World Diabetes Awareness Day?
Diabetes is an illness that is purely determined by the laboratory, because the diagnosis of diabetes is 100% dependent on the lab’s test result.
READ MORE